Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


340B Providers Should Report How They Use Drug Savings, House Members Say

This article was originally published in The Pink Sheet Daily

Executive Summary

Energy and Commerce Committee Republican members indicate particular concern with knowing how hospitals use drug discount savings to improve patient care.


Related Content

Hospital Drug Discount Transparency Bill Faces Heavy ‘Lift’ In Congress
340B Needs Legislative Fix For Overspending On Medicare Patients, GAO Says
Goodbye ‘340B,’ Hello ‘Outpatient Drug Discount Program’ In House Reform Bill
340B Manufacturer Audits Ramping Up In 2015
Congress Seeks Assurances 340B Program Benefits Vulnerable Patients
340B Lobby Group Seeks Bill Changing Hospital Eligibility For Discount Drugs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts